摘要:
The present invention concerns therapeutically effective terpinen-4-ol based compositions with a broad spectrum of the activity against a wide range of mastitis causing bacteria of the genera Staphylococcus spp, Streptococcus spp, Escherichia sppp, Enterococcus spp, Serratia spp, Klebsiella spp, Aeromosas spp, and methods for preventing, treating and controlling mastitis in milk producing animals and for reducing its spread in dairy herds are described.
摘要:
The present invention relates to a new combination of marker genes for characterizing a Lactobacillus sakei strain. In particular, the present invention concerns the use of a pattern of presence or absence of marker genes in the genome of the strain to be characterized for classifying and identifying said strain.
摘要:
The present invention concerns a method for manufacturing cheese with a final targeted mass value, characterised in that the cheese mass loss is controlled during its ripening, and in that said method comprises the steps of (i) determining, with an appropriate mass sensor, the cheese mass during its ripening in a ripening chamber; and (ii) modifying the relative humidity in the ripening chamber for obtaining the final targeted cheese mass value; a device comprising means for performing a said method; a computer program for controlling a computer to perform said method; and a computer readable medium containing said computer program.
摘要:
The invention concerns novel synthetic or natural peptides useful in particular for treating viral or parasitic infections or in the treatment of tumors, said peptides being less than 30 amino acids in size, preferably less than 20 amino acids, in particular 15 to 20 amino acids, and characterised in that they specifically bind, in vitro, a protein phosphatase 2A holoenzyme or one of its subunits. The invention also concerns a method for identifying such peptides, and their uses.
摘要:
The invention concerns the use of a genomic marker comprising a nucleotide sequence corresponding to all or part of the nucleotide sequence SEQ ID N°1, or to all or a part of an allele of the nucleotide sequence SEQ ID N°1.and associated with the phenotype relating to the tenderness of the meat from bovines, for the implementation of any identification method for the quantification of DNAJA1 expression level with the aim of selecting and/or sorting ruminant animals of the bovine type which produce tender meat and/or for the implementation of an identification method of tender meats at the moment of slaughter by direct sampling from the carcass. The invention concerns identification methods using the real time RT- PCR technique, the hybridization of labelling cDNA with an oligonucleotide probe and the detection of antigen-antibody complexes.
摘要:
This invention concerns a computer-implemented method for estimating diversity in a sample, which can apply to any sample, and in particular to a sample whom species distribution is unknown. The method of the invention comprises steps essentially involving two components, (a) a migration of a sample comprising molecules on a surface area, whereby molecules migrate on a surface area according to their nucleotide or aminoacid sequence and (b) method steps for the diversity measurement, which are preferably performed through the working of one or several computer program(s).
摘要:
The invention relates to N protein fusion proteins of interest, possibly in the form of N protein protein of interest/P protein soluble complexes, the N and P proteins being proteins of a virus in the Paramyxoviridae family. When the protein of interest is an antigen, the invention also relates to vaccine compositions and reagents of the diagnostic comprising these N protein-antigen fusion proteins or these N protein-antigen/P protein complexes. The N protein-protein of interest fusion may also be used as a 'vector' to transport therapeutic molecules of interest in the cells, such as antiviral or anticancer molecules.
摘要:
The present invention relates to the use of cells containing in their genome a specific DNA molecule, as cytopathic agents able to inhibit the proliferation of cells, when these proliferative cells are contacted with the cells containing the above-mentioned DNA molecule.